About Us
Our Story
At the end of 2005, a number of us involved with medical data systems where at a conference in London discussing the newest developments in clinical research. But instead of talking about new advances, speakers primarily alluded to the difficulty of finding the right study volunteers for trials.
Subsequent discussions with patients quickly brought to light that a method to easily access trials for study volunteers was missing. While there are many study registers, they are not targeted at volunteers. This lack of a central trial database, focused on the needs of study volunteers, inspired us to launch the ClinLife.
Today the ClinLife is a team of physicians and web developers, facilitating clinical research by connecting patients and study volunteers with clinical trials.
Mission
Our mission is to enable access to clinical trials for all wishing to be involved and to promote the benefits of clinical trials. Toward this goal we are building a network of patients, study volunteers, physicians, investigators, and others involved in this field.
We hope to become the leading clinical trials community in the UK, aimed at promoting research in medicine and healthcare.
Services
For study volunteers we currently offer registration and notification services.
For investigators and SMOs we currently offer study publication services. If you would like information on our services for health care professionals, please visit our professional section.
Allergy Notification Service
Did you not find a clinical study of interest for you? ClinLife will inform you as soon as we publish a allergy trial. Please click on „Register for this trial“ and follow the registration process:
Chronic obstructive pulmonary disease
The principal aim of the study is to evaluate whether attendance at an exercise training and education programme (known as pulmonary rehabilitation) shortly following hospital discharge can lead to a reduction in exacerbations and improvement in exercise
Currently there are no featured sites. Please check back later.
